PRCP
LFCR icon

Pacific Ridge Capital Partners’s Lifecore Biomedical LFCR Stock Holding History

Pacific Ridge Capital Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-416,861
Closed -$2.7M – 131
2022
Q4 		$2.7M Sell
416,861
-68,909
-14% -$568K 0.64% 61
2022
Q3 		$4.32M Sell
485,770
-12,242
-2% -$124K 1.12% 44
2022
Q2 		$4.96M Sell
498,012
-42,725
-8% -$423K 1.17% 39
2022
Q1 		$6.26M Buy
540,737
+1,283
+0.2% +$14.3K 1.19% 39
2021
Q4 		$5.99M Sell
539,454
-5,773
-1% -$56K 1.07% 48
2021
Q3 		$5.03M Sell
545,227
-26,459
-5% -$288K 0.93% 50
2021
Q2 		$6.43M Buy
571,686
+5,125
+0.9% +$59.1K 1.16% 42
2021
Q1 		$6.01M Buy
566,561
+41,092
+8% +$462K 1.14% 46
2020
Q4 		$5.7M Sell
525,469
-65,941
-11% -$681K 1.39% 23
2020
Q3 		$5.75M Sell
591,410
-23,980
-4% -$228K 1.63% 16
2020
Q2 		$4.9M Buy
615,390
+75,827
+14% +$782K 1.34% 32
2020
Q1 		$4.69M Buy
539,563
+25,341
+5% +$264K 1.76% 15
2019
Q4 		$5.82M Buy
514,222
+81,836
+19% +$871K 1.31% 28
2019
Q3 		$4.7M Buy
432,386
+16,094
+4% +$175K 1.22% 34
2019
Q2 		$3.9M Buy
416,292
+108,361
+35% +$1.09M 1% 49
2019
Q1 		$3.78M Buy
307,931
+46,193
+18% +$564K 1.01% 45
2018
Q4 		$3.1M Sell
261,738
-250
-0.1% -$3.43K 1.03% 37
2018
Q3 		$3.77M Sell
261,988
-15,978
-6% -$221K 0.97% 43
2018
Q2 		$4.14M Buy
277,966
+15,564
+6% +$216K 0.96% 42
2018
Q1 		$3.42M Sell
262,402
-740
-0.3% -$9.72K 0.92% 45
2017
Q4 		$3.32M Buy
263,142
+9,010
+4% +$114K 0.88% 49
2017
Q3 		$3.29M Sell
254,132
-4,700
-2% -$62K 0.93% 45
2017
Q2 		$3.84M Sell
258,832
-18,230
-7% -$254K 1.13% 34
2017
Q1 		$3.33M Buy
277,062
+50,090
+22% +$634K 0.95% 46
2016
Q4 		$3.13M Sell
226,972
-45,940
-17% -$636K 1.13% 40
2016
Q3 		$3.66M Sell
272,912
-9,036
-3% -$109K 1.51% 14
2016
Q2 		$3.03M Sell
281,948
-12,050
-4% -$133K 1.37% 18
2016
Q1 		$3.09M Buy
293,998
+1,090
+0.4% +$12K 1.38% 17
2015
Q4 		$3.46M Buy
292,908
+13,610
+5% +$167K 1.55% 8
2015
Q3 		$3.26M Sell
279,298
-8,066
-3% -$107K 1.6% 11
2015
Q2 		$4.15M Sell
287,364
-10,044
-3% -$145K 1.73% 7
2015
Q1 		$4.15M Buy
297,408
+8,660
+3% +$120K 1.64% 8
2014
Q4 		$3.99M Buy
288,748
+1,058
+0.4% +$13.7K 1.69% 7
2014
Q3 		$3.52M Buy
287,690
+74,280
+35% +$927K 1.82% 4
2014
Q2 		$2.67M Sell
213,410
-1,690
-0.8% -$19.9K 1.82% 4
2014
Q1 		$2.4M Buy
215,100
+113,570
+112% +$1.25M 1.65% 11
2013
Q4 		$1.23M Buy
+101,530
New +$1.21M 0.84% 47

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Pacific Ridge Capital Partners's LFCR Position: Q1 2023 in Review

Pacific Ridge Capital Partners sold out of Lifecore Biomedical (LFCR) in Q1 2023, closing a stake of 416,861 shares — an estimated $2.7M sold.

Pacific Ridge Capital Partners first reported a position in LFCR in Q4 2013 and held it in 37 quarters. The position peaked at $6.43M in Q2 2021. 82 funds tracked by Wall St. Rank hold LFCR as of Q1 2023.

  • Pacific Ridge Capital Partners reported no remaining Lifecore Biomedical position as of Q1 2023 after selling out during the quarter.
  • Pacific Ridge Capital Partners sold 416,861 Lifecore Biomedical shares in Q1 2023, an estimated $2.7M.
  • Pacific Ridge Capital Partners first reported a position in Lifecore Biomedical in Q4 2013 and held it in 37 quarters.
  • Pacific Ridge Capital Partners's Lifecore Biomedical position peaked at $6.43M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2023.

Based on Pacific Ridge Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.